1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.2174/157015911795017399" target="_blank" rel="noreferrer noopener">http://doi.org/10.2174/157015911795017399</a>
Pages
40–44
Issue
1
Volume
9
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity.
Publisher
An entity responsible for making the resource available
Current neuropharmacology
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-03
Subject
The topic of the resource
Body Temperature; Body Weight; Bcl-2 PAI-1; Dopamine Transporter.; GFAP; IGF-1R
Creator
An entity primarily responsible for making the resource
Dluzen D E; McDermott J L; Bourque M; Di Paolo T; Darvesh A S; Buletko A B; Laping N J
Description
An account of the resource
Three different approaches were employed to assess various markers associated with sex differences in responses to methamphetamine (MA). Bioassay measures reveal that MA treatment results in significantly greater reductions in body weight and increases in body temperature in male mice. Protein and mRNA determinations show significant increases in Bcl-2 and PAI-1 in male mice, while females show significant increases in GFAP and decreases in IGF-1R following treatment with MA. In mice with a heterozygous mutation of their dopamine transporter (+/- DAT), only female mice show significant differences in dopamine transporter binding and mRNA and associated reductions in striatal dopamine content along with increases in MA-evoked striatal dopamine output. The identification of these sex-dependent differences in markers provides a foundation for more exhaustive evaluation of their impact upon, and treatment of, disorders/neurotoxicity of the nigrostriatal dopaminergic system and the bases for the differences that exist between females and males.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.2174/157015911795017399" target="_blank" rel="noreferrer noopener">10.2174/157015911795017399</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
Bcl-2 PAI-1
Body Temperature
Body Weight
Bourque M
Buletko A B
Current neuropharmacology
Darvesh A S
Department of Pharmaceutical Sciences
Di Paolo T
Dluzen D E
Dopamine Transporter.
GFAP
IGF-1R
Laping N J
McDermott J L
NEOMED College of Pharmacy